After completing this activity, pharmacists should be able to:
- Describe the risks of COVID-19 and common comorbidities causing serious complications
- Describe the implications of COVID-19 in people with chronic obstructive pulmonary disease
- Describe how to reduce the risk of exacerbation and hospitalisation of people with COPD during the COVID-19 pandemic.
The 2016 Competency Standards addressed by this activity include: 3.1, 3.2, 3.3, 3.6
Accreditation number: A2004COVID19-2 Accreditation expires: 31/08/2020
This activity has been accredited for 0.75 hour of Group One CPD (or 0.75 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 0.75 hour of Group Two CPD (or 1.5 CPD credits) upon successful completion of the associated assessment activity.